ReviewCancers2022
Measurable Residual Disease in High-Risk Acute Myeloid Leukemia.
Thomas Cluzeau et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
9 papers cite it
this papercites it
ReviewCancers2022
Thomas Cluzeau et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.